SLC5A2 and liver disorder: PubMed and Google Scholar were systematically searched from database inception through December 2024 using combinations of the following terms: “sodium‐glucose cotransporter‐2 inhibitors”, “SGLT2 inhibitors”, “empagliflozin”, “dapagliflozin”, “canagliflozin”, “ertugliflozin”, “liver cirrhosis”, “decompensated cirrhosis”, and “portal hypertension”.